【Japan Pharmaceutical Association, Japanese Society of Hospital Pharmacists issued attention notice】Considerations during medication instruction of Olaparib

ISPACOS visited the Japan Pharmaceutical Association on August 5, 2019, and the Japanese Society of Hospital Pharmacists on November 6, 2019, and submitted a written request for “Considerations for Olaparib during Medication Instruction (Request).” On Feburary 21, 2020, both pharmaceutical associations issued attention notice. We are pleased to report that the voices of patients have become a great source of energy to move professional organizations and have led to the awareness of pharmacists.